BOLT BIOTHERAPEUTICS, INC.
900 Chesapeake Drive
Redwood City, California 94063
February 2, 2021
VIA EMAILAND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
ATTN: Mr. Donald Field
Ms. Sonia Bednarowski
Ms. Kristin Lochhead
Mr. Daniel Gordon
| RE: | Bolt Biotherapeutics, Inc. |
Registration Statement on Form S-1
File No. 333-252136
Ladies and Gentlemen:
Bolt Biotherapeutics, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on February 4, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of John McKenna and Sonya Erickson of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with John McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059, or in his absence, Sonya Erickson at (206) 452-8753.
[SIGNATURE PAGE FOLLOWS]
| Very truly yours, | ||
| BOLT BIOTHERAPEUTICS, INC. | ||
| By: | /s/ William P. Quinn | |
| Name: | William P. Quinn | |
| Title: | Chief Financial Officer | |
| cc: | Randall C. Schatzman, Ph.D., Bolt Biotherapeutics, Inc. |
John T. McKenna, Cooley LLP
Sonya F. Erickson, Cooley LLP
Julia Stark, Cooley LLP
Colleen E. Badgley, Cooley LLP
Alan F. Denenberg, Davis Polk & Wardwell LLP
Bryan M. Quinn, Davis Polk & Wardwell LLP
[COMPANY SIGNATURE PAGETO ACCELERATION REQUEST]
